Form 8-K - Current report:
SEC Accession No. 0000950170-25-092176
Filing Date
2025-07-01
Accepted
2025-07-01 16:01:34
Documents
10
Period of Report
2025-06-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K scyx-20250625.htm   iXBRL 8-K 108379
  Complete submission text file 0000950170-25-092176.txt   215646

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT scyx-20250625.xsd EX-101.SCH 24862
12 EXTRACTED XBRL INSTANCE DOCUMENT scyx-20250625_htm.xml XML 4706
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 251096202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)